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Abstract
Background:  Transgenic mice have proven to be a powerful system to study normal and
pathological gene functions. Here we describe an attempt to generate a transgenic mouse model
for choroideremia (CHM), a slow-onset X-linked retinal degeneration caused by mutations in the
Rab Escort Protein-1 (REP1) gene. REP1 is part of the Rab geranylgeranylation machinery, a
modification that is essential for Rab function in membrane traffic. The loss of REP1 in CHM
patients may trigger retinal degeneration through its effects on Rab proteins. We have previously
reported that Rab27a is the Rab most affected in CHM lymphoblasts and hypothesised that the
selective dysfunction of Rab27a (and possibly a few other Rab GTPases) plays an essential role in
the retinal degenerative process.
Results:  To investigate this hypothesis, we generated several lines of dominant-negative,
constitutively-active and wild-type Rab27a (and Rab27b) transgenic mice whose expression was
driven either by the pigment cell-specific tyrosinase promoter or the ubiquitous β-actin promoter.
High levels of mRNA and protein were observed in transgenic lines expressing wild-type or
constitutively active Rab27a and Rab27b. However, only modest levels of transgenic protein were
expressed. Pulse-chase experiments suggest that the dominant-negative proteins, but not the
constitutively-active or wild type proteins, are rapidly degraded. Consistently, no significant
phenotype was observed in our transgenic lines. Coat-colour was normal, indicating normal Rab27a
activity. Retinal function as determined by fundoscopy, angiography, electroretinography and
histology was also normal.
Conclusions: We suggest that the instability of the dominant-negative mutant Rab27 proteins in
vivo precludes the use of this approach to generate mouse models of disease caused by Rab27
GTPases.
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Background
Membrane traffic in eukaryotic cells is mediated by vesic-
ular carriers, which bud from a donor compartment, are
targeted to, and fuse with the appropriate acceptor mem-
brane. The Rab family of Ras-like GTPases is known to
play a crucial role controlling these mechanisms [1,2].
Among Rabs, the Rab27 subfamily consists of two isofor-
ms, Rab27a (previously designated Ram) [3] and Rab27b
(previously designated c25KG) [4].
In order to function in membrane traffic, Rabs require the
covalent addition of one or two C20 geranylgeranyl
groups [5,6]. Geranylgeranylation serves as a membrane-
anchoring device in Rab proteins [5]. This reaction is com-
plex and occurs in several steps. Newly synthesised Rab
proteins first associate with Rab Escort Protein (REP) and
form a stable 1:1 complex [7,8]. The complex then serves
as a substrate for Rab geranylgeranyl transferase to cata-
lyse geranylgeranylation via thioether bonds to carboxy-
terminal cysteine residues in Rabs [9,10]. Alternatively,
newly synthesised Rabs can associate with a pre-formed
REP:Rab-geranylgeranyl-transferase complex [11]. After
geranylgeranylation, the REP:Rab complex is competent
for delivery of the newly prenylated protein to cellular
membranes by a process that has not been characterised
[12,13].
The human genome contains two related REP genes, REP1
and REP2 [14]. Loss-of-function mutations in REP1 result
in choroideremia, an X-linked slow-onset retinal degener-
ation that affects photoreceptors, retinal pigment epitheli-
um and the choroid [8,15]. We have speculated that the
disease is caused by selective defects in Rab geranylgeran-
ylation in the affected retinal cells and have identified
Rab27a as one Rab that appears selectively unprenylated
in choroideremia lymphoblasts [16]. Thus, Rab27a,
which is expressed at high levels in the retinal pigment ep-
ithelium and choroid, could play an important role in
triggering the degenerative process in choroideremia
[16,17].
The rationale for the present study was to generate trans-
genic mice expressing dominant-negative mutant Rab27
proteins in order to interfere with the function of the wild
type alleles and disrupt the Rab27 regulatory function. We
found that dominant-negative Rab27 proteins are unsta-
ble and quickly degraded in vivo, and are thus unable to
generate a dominant-interfering effect.
Results
Construction of transgenic vectors
Previous studies indicated that selective point mutations
in Ras-like proteins that interfere with the cycle of GTP
binding and hydrolysis produce either dominant-negative
or constitutively-active mutant proteins [18]. Equivalent
mutations were introduced into Rab27a cDNA with the
predicted effects indicated in Table 1. In order to study
whether Rab27a played a role in the retinal degenerative
process observed in choroideremia, we wished to generate
transgenic mouse lines expressing dominant-negative
Rab27a.
We constructed two sets of transgenic lines. For one set we
took advantage of the tyrosinase tissue-specific promoter
to drive expression of the transgene in pigmented cells in-
cluding retinal pigment epithelium and choroidal
melanocytes, given that these cell types are probably the
primary site of degeneration in choroideremia [15,19,20].
cDNAs for Rab27a wild-type, dominant-negative mutants
(Rab27aT23N and Rab27aN133I) and constitutively-active
mutant (Rab27aQ78L) were cloned downstream of the ty-
rosinase promoter and upstream of the human growth
hormone. Figure 1A provides a schematic diagram of the
PTyr/Rab27a/hGH expression constructs. These con-
structs include a 2,200-bp fragment of the tyrosinase pro-
moter, a 650-bp rat Rab27a coding sequence and 600-bp
of sequence derived from the human growth factor gene,
which provides a polyadenylation signal. To generate
transgenic lines, a 3.4 kb XhoI – NotI fragment containing
the expression cassette was injected into (C57BL/6JxCBA)
embryos according to standard procedures [21]. For the
second set, we used the chicken β-actin promoter to
achieve ubiquitous and high level expression of the trans-
genes in the mice [22,23]. Figure 1B provides a schematic
diagram of the PCAG/myc-Rab27/β-globin expression
constructs, which include a 1,235-bp fragment of chicken
β-actin promoter, a 365-bp CMV-IE enhancer, a 33-bp
myc-tag fragment, a 650-bp rat Rab27a or human Rab27b
coding sequence and 525-bp of the rabbit β-globin poly-
adenylation signal. To generate transgenic lines, a 3.4-kb
SpeI – BamHI fragment containing each expression cas-
sette was injected into (C57BL/6JxCBA) embryos accord-
ing to standard procedures [21].
Production of transgenic lines
Transgenic lines generated following injection of the
PTyr/Rab27a/hGH or PCAG/myc-Rab27/β-globin con-
structs were named according to the nomenclature indi-
cated in Table 2. Mice containing the Rab27a transgenes
were identified by PCR using primers specific to the tyro-
sinase promoter or myc-epitope (5' primer) and Rab27a
cDNA (3' primer) (data not shown). In addition, each line
was subjected to Southern blotting. Figure 2 shows a typ-
ical Southern blot screening following KpnI digestion and
hybridisation using the entire coding sequence of Rab27a
as a probe. Note that KpnI cuts the transgene once be-
tween the myc-tag and the coding sequence of Rab27a.
Thus, a single transgenic integration will generate one hy-
bridising fragment in addition to the endogenous bands.
A tandem array of transgenes will generate two bands, oneBMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/26
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at 3.4 kb corresponding to the transgenic array and one of
variable size corresponding to the Rab27a cDNA nearest
the adjacent genomic DNA. As shown in Figure 2, DNA
from mouse 21 showed a single extra band, suggesting a
single integrated copy while DNA from mouse 25 exhibit-
ed one band at about 12 kb and one at 3.4 kb suggesting
tandem integration. An accurate number of transgenic se-
quences per cell was not determined in part because the
transgene expression was independent of transgene copy
number, as previously reported [24,25]. For all the con-
structs injected, the germ line integration was approxi-
mately 20% and thus quite efficient. At least two founders
that transmit each transgene were generated. All the
founder animals (F0) obtained were successfully bred
with C57BL/6J mice to establish transgenic lines. We also
attempted to generate homozygous transgenic mice but
this was only possible for a restricted number of lines.
Transgene mRNA expression
The expression of the transgenes was initially assessed us-
ing an RT-PCR assay on total RNA extracted from eye tis-
sue (Fig. 3). We designed an assay where both transgenic
and endogenous Rab27a mRNA could be amplified by se-
lecting primers that would anneal equally well to the
mouse and rat sequences. The RT-PCR products were then
digested with EcoRI (cutting only the rat sequence) or
SmaI (cutting only the mouse sequence) restriction en-
zymes to distinguish between endogenous and transgen-
ic-derived products (Fig. 3A). This assay allowed us to
distinguish between lines that do not express significant
amounts of the transgene, such as A27aT25/1 from those
that express high levels, such as A27aT25/2 (Fig. 3B). Al-
most all actin promoter-driven transgenic lines expressed
high levels of transgenic mRNA as revealed by this assay.
To quantify approximately the level of expression, the
Rab27a or Rab27b product was compared to Hprt product
(Fig. 3C and Table 3). All actin promoter-driven transgen-
ic lines tested, except A27aT25/1, appeared to express the
transgene at significant levels, approximately 3–12 times
higher than the endogenous counterpart. Conversely, the
expression levels in tyrosinase promoter-driven trans-
genes were much lower, typically not exceeding 3-fold
over the endogenous levels (data not shown).
Transgenic protein expression by immunoblotting
The pCAG/myc-Rab27/β-globin expression constructs
carry a myc tag fused to the Rab27 protein, which allowed
the transgenic protein to be easily quantified. We pre-
pared spleen lysates from transgenic mice and subjected
them to immunoblotting analysis. Spleen was chosen be-
cause it contains relatively high amounts of endogenous
Rab27a, which could be used as an internal control [16].
We used initially a specific monoclonal anti-Rab27a anti-
body, 4B12 as a probe and observed a 27-kDa band corre-
sponding to the endogenous Rab27a protein in all lysates
tested (Fig. 4A). In addition, a slower migrating band was
also detected in samples prepared from some of the trans-
genic mice, corresponding to the myc-tagged transgenic
protein as confirmed by immunodetection using the anti-
myc antibody (Fig. 4B). To assess the range of tissues in
which transgenic protein was expressed, twelve different
organs (eye, spleen, liver, skin, lung, kidney, stomach,
large intestine, small intestine, brain, testis and heart)
were harvested and subjected to Western blotting analysis
using anti-Rab27a or anti-myc specific probes. Examples
where lines A27aQ24 (Rab27aQ78L) and A27aT25/2
(Rab27aT23N) were analysed are presented in Figure 4.
The pCAG/myc-Rab27/β-globin constructs carrying the
wild-type and constitutively-active mutant (Rab27aQ78L)
forms of Rab27a were found to express transgenic protein
ubiquitously and at very high levels, usually more than
ten times the endogenous levels (Fig. 4B and data not
shown). In contrast the pCAG/myc-Rab27/β-globin con-
structs carrying dominant negative mutant Rab27aT23N,
Rab27aNI33I, Rab27bT23N and Rab27bNI33I gave much
lower levels of protein. The highest levels of dominant
negative protein were observed in the line A27aT25/2 as
shown in Fig. 4A. The amount of transgenic protein ex-
pressed in A27aT25/2 was relatively constant from tissue
to tissue. In tissues where endogenous Rab27a expression
was high, the levels of Rab27aT23N transgenic protein
were nearly equal to or lower than, but never higher, than
endogenous protein (Fig. 4B). Lower levels of transgenic
protein expression were observed for the other lines ex-
pressing dominant-negative mutant Rab27a and Rab27b
(data not shown).
Figure 1
Organisation of transgenic constructs. Panel A depicts the
PTyr/Rab27a/hGH constructs and Panel B depicts the pCAG/
myc-Rab27/β-globin constructs generated as described under
"Methods". Point mutations are indicated by an asterisk.
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The results for the tyrosinase promoter-driven transgenes
were less clear as the transgenic protein did not contain an
epitope tag and could not be distinguished from the en-
dogenous protein. We have not been able to detect differ-
ences in the levels of Rab27a in any of the twelve tissues
described above (data not shown).
Turn-over of Rab27a mutants
The discrepancy between mRNA levels and protein levels
observed in the different transgenic lines suggested that
some mutant proteins might be unstable and rapidly de-
graded. To explore this possibility, we performed a pulse-
chase experiment to determine the approximate half-lives
of the transgenic proteins. COS-7 cells were transfected
with pCAG/myc-Rab27/β-globin constructs expressing ei-
ther Rab27aWT, Rab27aQ78L, Rab27aT23N or Rab27aN133I,
then metabolically labelled with [35S]methionine/
cysteine for 1 h, followed by different time intervals of
chase in the presence of non-radiolabelled medium. The
cells were then harvested, lysed and subjected to anti-
Rab27a immunoprecipitations. Under these conditions,
we observed that both myc-tagged wild type Rab27a and
Rab27aQ78L decayed with a half-life of approximately 24
h (Fig. 5A,5C,5E). In contrast, the dominant-negative mu-
tant proteins exhibited much shorter half-lives. Our re-
sults indicate that the half-life of myc-Rab27aT23N is
approximately 2.5 h while that of myc-Rab27aN133I is ap-
proximately 6 h (Fig. 5B,5D,5E). These results suggest that
dominant-negative Rab27a mutants are unstable and de-
grade rapidly in comparison with wild type Rab27a.
Phenotypic characterisation: coat colour
While this work was in progress, Jenkins and co-workers
reported that a Rab27a loss-of-function mutation leads to
Figure 2
Screening of transgenic mice. Southern analysis was performed using mouse genomic DNA extracted from the tail of potential
Rab27aT23N and Rab27aN133I transgenics. Each well contains genomic DNA extracted from an individual mouse tail biopsy and
electrophoresed on an agarose gel as described under "Methods". The band around 3.4 kb suggests the presence of an array of
transgenes.
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Figure 3
Detection of Rab27a mRNA. (Panel A) Schematic depiction of transgenic (rat) versus endogenous (mouse) Rab27a coding
sequence. EcoRI or SmaI restriction sites as well as resulting fragment sizes are indicated. (Panel B) Comparison of transgenic
versus endogenous Rab27a expression in the eye by RT-PCR and restriction digestion of PCR products. Rab27a mRNA from
wild-type and independent mutant transgenic lines (Rab27aT23N and Rab27aN133I) amplified by RT-PCR was digested with
EcoRI or SmaI and electrophoresed as described under "Methods". Rat Rab27a cDNA was used as a control. (Panel C) Deter-
mination of Rab27a expression (transgenic and endogenous) in eyes by RT-PCR (+). The oligonucleotides and conditions were
as described under "Methods". The PCR products were analysed on an agarose gel stained with ethidium bromide. Reactions
performed without reverse transcriptase are indicated (-). The arrows on the left-hand side indicate the positions of DNA
marker sizes. Hprt expression was used as an internal control.
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the phenotype observed in the ashen mouse [26]. The ash-
en mouse is a model for Griscelli Syndrome (GS), which
is caused by Rab27a mutations [26,27]. The phenotype of
GS is characterised by partial albinism (coat colour dilu-
tion in the mouse) and loss of cytotoxic T-lymphocyte
(CTL) killing activity resulting in immunodeficiency. We
therefore predicted that our transgenic mice expressing
dominant-negative Rab27a mutants would show coat col-
our dilution if a dominant-negative effect had resulted in
vivo. Figures 6A and 6B show representative photographs
of dominant-negative mutant transgenic mice, demon-
strating no apparent lightening of coat colour similar to
that seen in ashen mice. Coat colour dilution in ashen mice
is probably due to defects in distribution of melanosomes
in skin melanocytes. However, microscopic examination
of hair shafts from mutant Rab27a transgenic animals re-
vealed no clusters of aggregated melanin in follicular
melanocytes similar to those observed in ashen skin (data
not shown). In addition, the Rab27aQ78L and wild-type
transgenic mice expressing very high levels of transgenic
protein did not present any obvious skin alterations (data
not shown).
To test the functionality of the transgenic Rab27a proteins
in vivo, we produced mice where the transgenic protein
was the only source of Rab27a. This was accomplished by
crossing the transgenic lines twice with ashen homozygous
mice to obtain homozygous ashen mice carrying the trans-
genes. The offspring were genotyped [28] and examined
for coat colour. As expected, the wild-type Rab27a trans-
gene was able to rescue the ashen mice coat colour nearly
completely (Fig. 6C) while the dominant-negative
Rab27aT23N transgene did not (Fig. 6D). Mice that were
homozygous for the ashen mutation and carried the con-
stitutively-active mutant Rab27aQ78L transgene (ash/ash, -
/tgRab27aQ78L) partially rescued the coat colour defect
(Fig. 6D). This effect was strengthened by transgene ho-
mozygosity. Transgenic ash/ash, tgRab27aQ78L/tgRab27aQ78L
mice were almost entirely rescued to wild type coat colour
(data not shown).
Phenotypic characterisation: vision
Despite the lack of a coat colour phenotype, we decided to
study retinal function in the transgenic mice. These stud-
ies included fundoscopy, angiography, electroretinogra-
phy and histology and were performed at different ages,
from 1 month to over 1 year old.
Table 1: Mutations affecting the GTP/GDP cycle of Rab27a
Rab27a mutation expected biochemical properties expected effect
T23N preferential binding of GDP dominant-negative
Q78L reduced GTPase activity constitutively-active
N133I low affinity for GDP/GTP dominant-negative
Table 2: Nomenclature for transgenic lines
promoter mutant Rab27 transgenic line identification*
tyrosinase Rab27aT23N T27aT*
Rab27aQ78L T27aQ
Rab27aN133I T27aN
β-actin Rab27aT23N A27aT
Rab27aQ78L A27aQ
Rab27aN133I A27aN
Rab27a wt A27awt
Rab27bT23N A27bT
Rab27bN133I A27bN
Rab27b wt A27bwt
* T – T23N; Q – Q78L and N – N133I; when multiple lines were obtained for the same construct these are identified numerically.BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/26
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Fundoscopy is a method that allows detection of gross ab-
normalities such as retinal or subretinal deposits, defects
in the RPE, new vascularisation and detachments of the
retina. The system allows rapid, inexpensive and serial ex-
amination of the retina and also obtaining very high qual-
ity images of the posterior segment of the mouse eye.
Figure 7 shows representative photographs of wild type
(C57BL/6J) and transgenic (Rab27aT23N) mice at 6
months of age. The examination of the fundus of trans-
genic mice revealed regular pigmentation at the level of
the RPE. The optic nerve and retinal blood vessels in fun-
dus seemed to be normal. Fundi of mice from all trans-
genic lines have been examined up to one year old and no
significant alterations have been detected, with one excep-
tion. The T27aT15 line exhibited extensive pathological
alterations in both the anterior and posterior segments of
the eye, which were probably caused by the disruption of
one or more genes at the site of transgene insertion (J.S.
Ramalho and M.C. Seabra, manuscript in preparation).
The retinal vasculature was examined by fluorescein angi-
ography, i.e., fundus photography combined with intrave-
nous fluorescein injection [29]. Neovascularisation that is
often present in retinal degeneration is easily identified. It
is also possible to detect defects in the RPE, since the mel-
anin in the RPE can attenuate the fluorescence from the
Figure 4
Expression of transgenic Rab27a proteins in mouse tissues. Protein extracts obtained from eyes, spleen, liver, skin, lung, kidney,
stomach, large intestine, small intestine, brain, testis and heart (50 µg each) were subjected to SDS-PAGE and probed with
monoclonal anti-myc-tag antibody (9E10) and/or a specific anti-Rab27a monoclonal antibody (4B12). Calnexin was used as a
loading control and detected using a specific polyclonal antibody. A protein extract of HeLa cells transfected with myc-
Rab27aT23N was used as a positive control. (Panel A) Tissues from the A27aT25/2 line carrying Rab27aT23N. (Panel B) Tissues
from the A27aQ24 line carrying Rab27aQ78L.
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Figure 5
Half-lives of wild-type, Rab27aT23N, Rab27aQ78L and Rab27aN133I mutant proteins. COS-7 cells transfected with either
pCAGGS myc-Rab27aWT (A), pCAGGS myc-Rab27aT23N (B), pCAGGS myc-Rab27aQ78L (C), or co-transfected with pCAGGS
myc-Rab27aWT and pCAGGS myc-Rab27aT23N (D) were labelled with [35S]methionine/cysteine for 2 h and subsequently
chased in Dulbecco's modified Eagle's medium for the indicated times. Rab27a protein was immunoprecipitated from cell
extracts, collected with protein G-Sepharose beads, separated on a 12% SDS-polyacrylamide gel and autoradiographed as
described under "Methods". (Panel E) Quantification of radiolabelled samples obtained above.
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choroidal circulation. Figure 8 depicts representative ex-
amples of fluorescein angiography from Rab27aT23N
transgenic mice (A27aT25/2 line) and wild-type litter
mates. The retinal vessels are clearly visualised 30 s after
injection. We observed no narrowing vessels, no abnor-
mal leakage of fluorescein dye from the retinal capillaries
and no hyperfluorescence of the retinal pigment epitheli-
um.
Another important complementary method of eye exami-
nation is Ganzfeld electroretinography (ERG). In a
Ganzfeld setup, the stimulus (usually a Xenon tube flash
of less than 1 ms duration) passes through a diffusor that
yields a relatively homogeneous distribution of light in-
tensity on the inside of a bowl. The term 'Ganzfeld' mean-
ing 'full field' denotes that the stimulus reaches practically
all parts of the retina and its intensity is approximately
equal across that area. For most applications, the ERG,
which is an electric sum potential generated by retinal
cells following exposure to light, is non-invasively meas-
ured at the corneal surface. Typically, the evoked response
consists of an initial negative deflection (a-wave), fol-
lowed by a large, positive component (b-wave). Superim-
posed on the ascending portion of the b-wave are the
oscillatory potentials (OPs), a set of wavelets oscillating
with approximately 4–5 times the frequency of the a- and
b-wave. Finally, a prolonged positive component (c-
wave) follows, which takes several seconds to develop.
Due to characteristic contributions of photoreceptors, bi-
polar cells, and amacrine cells, the ERG is a valuable indi-
cator of retinal function beyond the ganglion cell level. To
Table 3: Transgenic protein and mRNA expression.
Rab27 mutant line mRNA expression* transgenic protein expression
Rab27aT23N T27aT2 0.20 ± 0.02 not detectable
T27aT15 0.29 ± 0.03 not detectable
T27aT17 0.31 ± 0.01 not detectable
T27aT20 0.29 ± 0.01 not detectable
A27aT6 2.6 ± 0.2 ++
A27aT6/18 not determined ++
A27aT13 1.8 ± 0.1
A27aT25/1 0.21 ± 0.03
A27aT25/2 1.7 ± 0.1 +++
Rab27aQ78L T27Q102 0.32 ± 0.06
A27aQ13 not determined §
A27aQ24 not determined §
Rab27aN133I T27aN14/5 0.61 ± 0.02 not detectable
T27aN48 0.26 ± 0.02 not detectable
A27aN2 0.95 ± 0.04 +
A27aN6 1.27 ± 0.08 +
A27aN14 2.2 ± 0.4 not detectable
Rab27a wt A27aTwt2 not determined +++
Rab27bT23N A27bT40 1.21 ± 0.03 +
A27bT59 0.6 ± 0.1 not detectable
Rab27bN133I A27bN9 1.64 ± 0.06 ++
+++ represents transgenic Rab27 protein level similar to endogenous, ++ or + represent transgenic Rab27 protein level below endogenous, §very 
high levels of transgenic protein compared to endogenous; * mRNA Rab27 values are expressed as (endogenous + transgenic Rab27a or Rab27b) / 
Hprt. Endogenous Rab27a/Hprt = 0.22 ± 0.01. Endogenous Rab27b/Hprt = 0.12 ± 0.01.BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/26
Page 10 of 17
(page number not for citation purposes)
assess whether potential functional changes in the trans-
genic lines could be picked up with this method, the lines
that presented higher levels of transgenic protein were
subjected to ERG at six months of age. Representative
lines from each transgenic construct were analysed at six
months and found to be indistinguishable from wild type
in all but one case. In A27aT25/2 mice (Rab27aT23N), the
b-wave amplitudes were all in the low-normal range (Fig.
9) but these differences were not statistically significant.
Interestingly, this transgenic line showed the highest level
of dominant-negative transgenic protein and thus the
low-normal ERG may have resulted from a dominant-
negative effect of mutant Rab27a. However, as only one of
the lines studied showed this result, the disruption of a
gene with important function in the retina upon transgen-
esis in the A27aT25/2 appears to be the most likely expla-
nation.
Finally, we performed histological analysis. Retinal cross-
sections subjected to conventional histochemical staining
taken from 10 month old Rab27aT23N (A27aT25/2 line)
and littermate control are shown in Figure 10. Again, we
observed no significant differences between the control
and the Rab27 transgenic animals. Note the normal thick-
ness of the outer nuclear layer, reflecting normal numbers
of photoreceptors in the retina.
Discussion
At the outset, we wished to investigate the possible role of
Rab27 proteins in human disease, in particular CHM. We
decided to generate transgenic mice expressing dominant-
negative forms of Rab27 for several reasons. Firstly, the
strategy of generating Rab proteins defective in either GTP
hydrolysis (constitutively-active) or GDP/GTP exchange
(dominant-negative) to selectively alter the function of in-
dividual Rab proteins in cultured cells has been extensive-
ly used previously (for example [30,31]). In some cases,
Figure 6
Photographs of representative transgenic and mutant mice. +/+, wild type C57BL/6J mouse; ash/ash, homozygous Rab27aashen
mutant mouse; -/tg, heterozygous transgenic of the indicated line.
A. B.
D.
ash/ash
+/+ +/+,
-/tgRab27aT23N
+/+,
-/tgRab27aQ78L
+/+
-/tgRab27aN133I
ash/ash
ash/ash
-/tgRab27aT23N
+/+
ash/ash
-/tgRab27aQ78L
ash/ash C.
ash/ash
-/tgRab27aWT ash/ash
+/+BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/26
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these mutants have had profound effects on membrane
trafficking such as with Rab5 [31], but in others such as
Rab11a the effects were more subtle [32]. Secondly, a
transgenic approach to express the equivalent Rab5 dom-
inant-negative mutant, Rab5N133I in immune cells report-
edly resulted in the desired phenotype [33]. Thirdly, this
approach was the best model for studying the partial dys-
function of Rab27a observed previously since dominant-
negative proteins would unlikely inactivate 100% of wild
type activity [15,16]. In addition, the dominant-negative
approach could also result in inactivation of Rab27b ac-
tivity, if not other related proteins. In contrast, a gene
knock-out approach would result in complete absence of
Rab27a while retaining full activity of the related protein
Rab27b. Our recent finding that Rab27b shows functional
redundancy with Rab27a further suggests that Rab27a-re-
lated Rabs may be involved in CHM [28]. Fourthly, we ob-
served that these same Rab27a mutations were effective in
cell culture models [34].
While this work was in progress, there was a considerable
advance in understanding the function of Rab27a and its
role in disease. Loss-of-function mutations in Rab27a
were observed in patients with Griscelli syndrome (online
Mendelian Inheritance in Man (OMIM) # 214450,  [http:/
/www.ncbi.nlm.nih.gov/Omim/]) and in the correspond-
ing mouse model, ashen [26,27]. GS is a rare, lethal auto-
somal recessive disorder, characterised by pigment
dilution of the hair (and to a lesser extent of skin) together
with early-onset immune deficiency with episodes of he-
mophagocytic (uncontrolled T lymphocyte and macro-
phage activation) syndrome [35,36]. The partial albinism
in GS patients is due to clumping of melanin pigment in
the hair shaft and accumulation of melanosomes around
the nucleus within melanocytes [34–38]. The immune de-
ficiency is due to loss of CTL killing activity [27,39,40]. If
the Rab27a mutant proteins Rab27aT23N and
Rab27aN133I acted as strong dominant-negative mutants,
as they do in cell culture [34,38], the transgenic lines gen-
erated should exhibit a phenotype resembling ashen mice,
possibly with additional phenotypes due to inactivation
of Rab27b as well. Unfortunately, no phenotype could be
detected in the transgenic lines. Coat colour was not af-
fected (Fig. 5) and CTL activity could not be studied given
that the β-actin promoter used in this study does not ex-
press in these cells [28]. We also performed detailed anal-
ysis of the retina in the transgenic lines, including
fundoscopy, angiography, histology and ERG, and could
not detect any significant pathological changes.
The lack of phenoytpe in the transgenic mice expressing
dominant-negative mutant Rab27a and Rab27b could
have been due to non-functional mutant proteins. How-
ever, this explanation seems unlikely as the same type of
mutants are functional in cultured melanocytes [34,38]. It
has been proposed that one mechanism for dominant-
negative action by these mutations in Ras-like proteins is
by competition for GDP/GTP exchange factors, required
for activation of the endogenous proteins [18]. Thus, the
absence of phenotype in these mice is probably due to in-
adequate levels of protein expression to elicit a dominant-
negative effect. Indeed, out of more than twenty transgen-
ic lines generated so far expressing dominant-negative
mutant forms of Rab27a or Rab27b, only one (A27aT25/
2) had transgenic protein levels close to the endogenous
counterpart (Fig. 4B).
The low levels of dominant-negative transgenic protein
are not due to poor expression of the transgenes as very
high levels of mRNA was observed in many of the lines. In
addition the wild-type and constitutively active proteins
were present at high levels from similar constructs. The
low levels of protein are probably due to more rapid turn-
over of the dominant-negative mutant proteins and we
observed that the Rab27aT23N and Rab27aNI33I proteins
have half-lives 4–8 times shorter than the wild type pro-
tein in tissue culture (Fig. 5). This fast turnover of the
dominant-negative protein compared to the constitutive-
ly-active and wild-type proteins probably results from a
combination of factors. The transgenic protein could be
poorly prenylated, a possibility supported by the finding
that only a small percentage of transgenic protein was
membrane-associated (data not shown). Also, the muta-
Figure 7
Photographs of the fundus of the Rab27aT23N transgenic
mouse. Wild-type (C57BL/6J control littermate) (A) and
Rab27aT23N transgenic mouse (A27aT25/2 line) (B) were
photographed at 6 months of age as described under "Meth-
ods". The venules (v) are twice the diameter of the arterioles
(a). The optical nerve head is indicated by an arrow. Note
that the two white dots are result of light reflection on the
lens between the camera and the mouse's eye.
A. C57BL/6J B. Rab27aT23N
v
a
v
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tion could reduce the stability of the tertiary structure of
the mutant protein resulting in an increased rate of un-
folding. Although the rate of turnover of Rab27b proteins
was not determined, the low levels of dominant negative
mutant protein in transgenic lines expressing high levels
of mRNA suggests that Rab27bT23N and Rab27bNI33I also
have high rates of turn-over. These observations in vivo
contrast with the effects observed in cultured cells, where
transient transfection leads to acute expression of very
high levels of mutant proteins.
Our initial hypothesis that Rab27a plays a role in the ret-
inal degenerative process of CHM remains untested given
the lack of success of this approach. As we proposed orig-
inally, it is unlikely that Rab27a is the only dysfunctional
Rab protein in this disorder and our inability to test reti-
nal tissue from patients has hampered the identification
of other Rabs that might be involved [16]. Nevertheless,
the availability of Rab27a knock-out mice (ashen) may al-
low us to determine whether Rab27a plays an important
role in retinal physiology and further elucidate the patho-
genesis of CHM.
Conclusions
The results presented here suggest that the use of domi-
nant-negative proteins in in vivo models should be careful-
ly considered. We report the generation of several
transgenic lines expressing dominant-negative mutants of
Rab27a and Rab27b where no phenotype could be elicit-
ed. The lack of a phenotype is likely due to the very mod-
est levels of protein expression, probably caused by rapid
degradation, despite very high levels of mRNA resulting
from transcription driven by a strong promoter in the
transgene.
Methods
Animals
All animals described here were maintained on 12-h light/
12-h dark conditions at Imperial College, CBS Unit, Lon-
don, UK, under Home Office Project Licence 70/5071.
Construction of mutant Rab27a transgenic vectors
Two general transgenic constructs were constructed, the
first contained the pigment cell-specific tyrosinase pro-
moter, Rab27a cDNA and the human growth hormone
poly A signal and the second contained the strong ubiqui-
tous chicken β-actin promoter and CMV-IE enhancer
(PCAG), followed by an amino-terminal myc-epitope-
tagged version of Rab27a or Rab27b, followed by rabbit β-
globin poly(A) signal (Fig. 1). The construction of the first
transgenic vector was initiated by subcloning a BamHI –
NotI fragment containing the human growth factor (hGH)
termination sequence [41,42] (a generous gift from David
Russell, University of Texas Southwestern Medical Center,
Dallas, USA) into pBS containing a 2.2 kb insert corre-
sponding to mouse tyrosinase promoter (a generous gift
from Paul Overbeek, Baylor College of Medicine, Hou-
ston, USA) [19,20]. For the second transgenic construct,
the promoter and poly A regions were from pCAGGS
[22,23]. The point mutations, Rab27aT23N, Rab27aN133I,
Rab27aQ78L, Rab27bT23N and Rab27bN133I were generat-
ed by PCR mutagenesis using the rat Rab27a or the hu-
man Rab27b cDNA as a template. The myc-epitope was
inserted in frame into the Rab27 cDNA by subcloning the
Rab27 cDNA into pCMV7-MYC [43] or pBS-MYC. pBS-
MYC was generated by cloning the ClaI/SalI-fragment
from pCMV7-MYC containing the myc-epitope into pB-
luescript SK. The fragments containing the myc-Rab27
cDNA were excised from pCMV7-MYC or pBS-MYC with
XbaI and BamHI or XhoI and BamHI, respectively. After gel
purification using QIAquick Gel Extraction Kit (Qiagen),
the recessed 3' termini were filled with 0.5 U of Klenow
fragment of Escherichia coli DNA polymerase I according
to the manufacturer's instructions. The product was then
subcloned into the blunted XhoI site of pCAGGS after Kle-
now fragment treatment (Fig. 1A).
Generation of the transgenic mice
A 3.4 kb XhoI – NotI fragment containing the Ptyr/
Rab27a/hGH or a 3.4 kb SpeI – BamHI fragment contain-
ing PCAG/myc-Rab27/β-globin were gel purified using
QIAquick Gel Extraction Kit (Qiagen) as described by the
manufacturer and eluted with 10 mM Tris-HCl (pH 8.5).
DNA was then dissolved in sterile 0.1 mM EDTA, 10 mM
Figure 8
Fluorescein fundus angiograms of Rab27aT23N transgenic
mouse retina. Angiograms of six monthsold wild-type
(C57BL/6J littermate control) (A and B) or Rab27aT23N
transgenic mouse (A27aT25/2 line) (C and D) taken one
minute after dye injection were obtained as described under
"Methods". The venules (v) are twice the diameter of the
arterioles (a). The arrow denotes the optical nerve.
A. C57BL/6J
B. C57BL/6J D. Rab27aT23N
C. Rab27aT23N
v
a
v
a
v
a
v
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Figure 9
Electrophysiological characteristics of the A27aT25/2 transgenic mouse line. (Panel A) Dark-adapted (scotopic) intensity series
of a six month-old wild-type control (left column) and a A27aT25/2 transgenic mouse (right column). Calibration marks: Verti-
cal 100 µV/div.; horizontal 40 ms/div. Stimulus intensities increased from top to bottom from 10-4 to 25 cd*s/m2. (Panel B)
Amplitude vs. intensity plot for the A27aT25/2 transgenic line in comparison to wild type mice. The crosses indicate the
median, the boxes the 25%- to 75%-quantiles, and the whiskers the 5%- to 95%-quantiles. The upper (95% quantile) and lower
(5% quantile) red line indicate the normal range based on wild type data.BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/26
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Tris-HCl (pH 8.0) at about 2 ng/µl and microinjected into
the pronuclei of one-cell stage embryos from a C57BL/
6JxCBA background collected from super-ovulated female
mice [21]. Microinjected eggs were transferred at two-cell
stage into the oviducts of pseudopregnant recipient fe-
males. Newborn mice were routinely screened for incor-
poration of the transgene by PCR and/or Southern
blotting.
Screening and generation of transgenic lines
Mice were genotyped by PCR amplification and by South-
ern blot analysis using genomic DNA obtained from
mouse-tail biopsy samples. The transgene was detected
with sense oligonucleotide JR119 (5'-AT-
GGAACAAAAACTCATCTCAGAAGAGG) corresponding
to the myc-tag sequence of the transgene or JR13 (5'-
ACATGTGATAGTCACTCCAGGGGTTGCT) correspond-
ing to tyrosinase promoter, and antisense oligonucleotide
JR14 (5'-AGTTGAACTTCCCATCAGTGTACTGGTA) corre-
sponding to the Rab27a coding sequence. Tail biopsies (~
0.5 cm) were digested with 40 µg/ml of proteinase K in
500 µl of extraction buffer containing 100 mM Tris-HCl
(pH 8.0), 200 mM NaCl, 5 mM EDTA and 0.2% SDS over-
night at 55°C followed by phenol/chloroform extraction.
After precipitation with isopropanol, DNA was washed
with 80% ethanol and resuspended in 50 µl of 10 mM
Tris-HCl (pH 8.5). For Southern blotting, approximately
20 µg of tail genomic DNA was digested with KpnI over-
night at 37°C. DNA was separated on a 0.8% TAE agarose
gel overnight at 120 mA and blotted onto Hybond-N+
(Amersham) membrane. Membranes were prehybridised
and hybridised with Rab27a or Rab27b probe, corre-
sponding to the entire Rab27 coding sequence, radiola-
belled with 20 µCi of [α-32P]dCTP by Random
Oligopriming (Amersham). In order to generate stable
transgenic lines, animals shown to be transgenic were sub-
sequently mated to wild-type C57BL/6J mice; transgene-
positive offspring (black colour mice) from these crosses
were likewise bred. Transgenic lines were maintained as
heterozygotes. Transgenic mice (Rab27T23N, Rab27aQ78L
and Rab27aWT) were crossed with ashen (ash/ash) on a
C57BL/6J background obtained by repeated backcrossing
of  ash/+ mice (over five generations) with wild-type
C57BL/6J mice [28]. The resulting heterozygous ashen (+/
ash) mice carrying the transgene were intercrossed to gen-
erate mice that carried the transgene on the ash/ash back-
ground. These mice were visually evaluated for the rescue
of the coat colour. The ashen mutation was screened for by
PCR using the primers ASH1 (5'-ACCTGACAAATGAGCA
AAGTTTCCTCAATG) and ASH2 (5'-GGAGCAGGGCAGG
GCTGGGGAAACCACTCG) followed by restriction en-
zyme analysis with TaqI and RsaI according to the proce-
dure described previously [28].
RT-PCR analysis
RT-PCR was carried out on total RNA obtained from eyes
and isolated using RNeasy (Qiagen). After total RNA iso-
lation, samples were treated with 1 U RNase-free DNase
for 45 min at 37°C to remove any transgenic DNA con-
tamination. The DNase was inactivated by heating for 15
min at 70°C. cDNA synthesis and DNA amplification
were carried out using 5 µg of total RNA. Labelling of the
PCR amplification product was carried out by addition of
0.025 µCi of [α-33P]dATP. DNA was amplified using only
23 cycles (exponential phase). PCR amplification of
Rab27a cDNA was performed with oligonucleotides JR62
(5'-GCATTGATTTCAGGGAAAAGAGAG) and JR63 (5'-
Figure 10
Histochemical staining of Rab27aT23N transgenic mouse ret-
ina. Transverse paraffin sections (3 µm) from 10 month-old
C57BL/6J (A) or Rab27aT23N transgenic mouse (line
A27aT25/2) (B) are shown. Magnification is approximately
×250. The abbreviations used are: sclera (SC), choroid (CH),
retinal pigment epithelium (RPE), photoreceptor segments of
rods and cones (ROS), nuclei of rods and cones (ONL),
outer synaptic layer (OSL), neuron nuclear layer (INL), inner
synaptic layer (ISL), ganglion cell layer (GCL), slender glial
(Muller) cell processes (M), ganglion cells (G) and inner limit-
ing membrane (IM).
SC
CH
RPE
ROS
ONL
OSL
INL
ISL
GCL
G IM
M
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TTCTCCACACACCGCTCCATCCGC). To ensure that both
transgenic and endogenous mRNA were amplified equal-
ly, these oligonucleotides were designed to be homolo-
gous to both endogenous (mouse) and transgenic (rat)
Rab27 cDNA. After amplification, the PCR products were
digested with Eco RI or Sma I to distinguish the mouse en-
dogenous from rat transgenic cDNA. In most cases, the
transgene expression was much higher than the endog-
enous expression making quantification impossible.
Therefore, the transgene expression level was determined
in each line by quantitating the Rab27 (endogenous plus
mutant mRNA) relative to Hprt cDNA using all four prim-
ers, 0.025 µCi of [α-33P] dATP and 23 cycles in PCR reac-
tion. The oligonucleotides used for Hprt amplification
were Hprt1 (5'-CCTGCTGGATTACATTAAAGCACTG) and
Hprt2 (5'-GTCAAGGGCATATCCAACAACAAAC). Possi-
ble contamination of mRNA with transgenic DNA was ex-
cluded by control reactions without reverse transcriptase.
The radiolabelled PCR products were separated on 2.5%
agarose gels, stained with ethidium bromide, transferred
onto 3 MM Whatman paper and quantified using a Cyclo-
tron Storage Phosphor Screen (Packard).
Immunoblot analysis
Immunoblotting was performed according to procedures
described elsewhere [16] with some modifications using
total, cytosol or membrane protein fractions obtained
from several C57BL/6J wild-type or transgenic tissues. All
the transgenic and non-transgenic mice used for immuno-
blotting studies were thoroughly perfused with phos-
phate-buffered saline (PBS) (pH 7.4) prior to dissection of
the tissue samples that included eye (the lens was always
removed from the ocular globe), spleen, liver, lung, kid-
ney, skin, stomach, large intestine, small intestine, brain,
testis and heart. Tissue samples were washed with PBS,
and thoroughly homogenised using a Polytron homoge-
niser in 3–5 volumes of homogenisation buffer contain-
ing 50 mM Tris-HCl (pH 7.5), 100 mM NaCl, 1 mM
phenyl-methylsulfonyl fluoride, 10 µg/ml leupeptin, 10
µg/ml aprotinin, 10 µg/ml pepstatin and 1 mM DTT. Ho-
mogenisation was followed by sonication for 5–10 sec-
onds. To sediment unbroken cells and cell nuclei, the
homogenates were centrifuged at 5,000 g for 30 min at
4°C. The postnuclear supernatant was then centrifuged at
100,000 g for 1 h at 4°C, resulting in the separation of cy-
tosolic (supernatant) and membrane (pellet) protein frac-
tions. The membrane fractions were resuspended into the
same volume of homogenisation buffer containing 1%
Triton X-100. The protein concentration was determined
only in the total fraction by BCA method (Pierce) accord-
ing to the manufacturer's instructions. For immunoblot
analysis, samples containing 50 µg of protein were sepa-
rated into soluble or membrane fractions and identical
volumes were subjected to SDS gel electrophoresis. After
being resuspended into loading buffer, protein samples
were loaded onto 12.5% SDS-polyacrylamide electro-
phoresis gels, run at 35 mA and transferred to Immobilon-
P polyvinylidene difluoride (Millipore) membrane in a
minitrans-blot cell (Amersham) at room temperature in a
buffer containing 25 mM Tris-HCl (pH 8.3), 192 mM gly-
cine, and 10% methanol for 1 h and 30 min at 500 mA.
To block non-specific binding sites, dried membranes
were incubated in blocking solution containing 0.1%
polyoxyethylenesorbitan monolaureate (Tween-20), 4%
non-fat milk in PBS for 1 h at room temperature. Mem-
branes were subsequently incubated with PBS/0.1%
Tween-20 solution supplemented with the following
preparation of antibodies: monoclonal 4B12 antibody
(0.3 µg/ml) anti-rat Rab27a [34], monoclonal antibody
anti-myc-tag (0.3 µg/ml) purchased from Oncogene
(Cambridge, MA, USA) or polyclonal anti-calnexin anti-
body (1:5,000) purchased from StressGene (Victoria, BC,
Canada). The mixture was incubated with the primary an-
tibody with gentle agitation for 1 h at room temperature,
rinsed and washed with PBS containing 0.1% Tween-20
for 15 min, 3 times. Membranes were then incubated with
horseradish peroxidase-coupled secondary antibody (Da-
ko). The blots were washed as described above and bands
were visualised by chemiluminescence using SuperSignal
West Pico Chemiluminescence Substrate (Pierce) accord-
ing to the instructions supplied by the manufacturer. All
blots were calibrated with prestained molecular weight
markers (Bio-Rad Laboratories).
Cell culture, transfections and labelling
COS-7 cells were maintained in Dulbecco's modified Ea-
gle's medium supplemented with 10% fetal bovine se-
rum. Transfections were performed using lipofectamine
(Qiagen). Total amounts of transfected DNA were 1 µg/6-
cm dish. For pulse-chase experiments, cells were washed
with methionine/cysteine-free medium and subsequently
incubated with 140 µCi of [35S]methionine/cysteine per
6-cm dish for 2 h. After this, cells were washed three times
in PBS, and further maintained in normal Dulbecco's
modified Eagle's medium supplemented with 10% fetal
bovine serum. At indicated time points (0, 30 min, 3, 5, 8
and 22 h), cells were lysed by incubation in buffer con-
taining 50 mM Tris-HCl (pH 7.5), 100 mM NaCl, 1 mM
phenyl-methylsulfonyl fluoride, 10 µg/ml leupeptin, 10
µg/ml aprotinin, 10 µg/ml pepstatin, 1 mM DTT and 1%
NP-40 for 20 min on ice followed by 5–10 s of sonication.
After centrifugation at 14,000 rpm, equal amounts of ra-
dioactive lysates were incubated under agitation with 5 µg
of 4B12 antibody for 1 h at RT, after lowering the concen-
tration of NP-40 to 0.5% by dilution. Subsequently, 30 µl
of protein G-Sepharose beads were added to the radioac-
tive material and incubated overnight at 4°C, while rock-
ing. Then beads were washed four times in PBS, denatured
in SDS-containing sample buffer and loaded on a 12%BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/26
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SDS-polyacrylamide gel, transferred onto 3 MM Whatman
paper and quantified using a Storm system (Amersham).
Fundus photography
Fundus photographs of mice were taken using a small an-
imal fundus camera (Kowa Genesis) according to John
and co-workers [29]. In order to have a better magnifica-
tion and focal depth of the fundus, the camera was used
in conjunction with an external 90 diopter condensing
lens (Volk). This condensing lens was mounted between
the camera and the mouse eye. The lens was placed about
5 cm below the camera. All the photographs were taken
without anesthesia and with mice's vibrissae trimmed to
avoid ocular clouding and obscuring photograph prob-
lems. Pupils were dilated with a drop of 1% Mydriacyl (Al-
con Laboratories) 20–30 min before taking the
photographs. For conventional photography of the fun-
dus, Kodak 200 ASA slide film was used. The photograph-
ic flash on the power pack was set up for its highest level
(position 6–7) for C57BL/6J mice as the highest intensity
of light produced better results on pigmented mice. The
mice were held beneath the external lens and the focusing
was achieved by moving the mouse. To reduce the light re-
flection, a major problem of this technique, the position
of the eye was very important. Accordingly, the procedure
involved focusing through an off central position of the
ocular globe.
Fluorescein angiography
The retinal angiography was performed using the general
fundus photography procedure. The camera was set up for
angiography through addition of an emission barrier filter
specific for fluorescein emission and the power pack was
set up for fluorescein angiography by changing the excita-
tion light to fluorescein excitation. For this type of pho-
tography Kodak black and white Tmax 400 ASA
professional film was used. The photographic flash on the
power pack was set up for its highest level (position 6–7).
Mice were intraperitoneally injected with 20% injectable
sodium fluorescein (Faure) at a dose of 10 µl per 5–6 g
body weight [44]. Photographs were taken at several inter-
vals, starting at 30 s post-injection.
Electroretinography
ERGs were obtained according to previously reported pro-
cedures [45]. Briefly, before anesthesia with ketamine
(66.7 mg/kg), xylazine (11.7 mg/kg), and atropine (1 mg/
kg), the pupils of dark-adapted mice were dilated. The
ERG equipment consisted of a Ganzfeld bowl, a DC am-
plifier, and a PC-based control and recording unit (Multi-
liner Vision, Jaeger/Toennies, Hoechberg, Germany).
Band-pass filter cut-off frequencies were 0.1 and 3000 Hz.
Single flash recordings were obtained both under dark-
adapted (scotopic) and light-adapted (photopic) condi-
tions. Light adaptation before the photopic session was
performed with a background illumination of 30 cd/m2
for 10 minutes. Single flash stimulus intensities were in-
creased from 10-4 cd*s/m2 to 25 cd*s/m2, divided into
ten steps of 0.5 and 1 log cd*s/m2. Ten responses were av-
eraged with an inter-stimulus interval (ISI) of either 5s or
17s (for 1, 3, 10, 25 cd*s/m2).
Histology
Eyes were fixed in 4% paraformaldehyde, 5% glutaralde-
hyde and 0.1 M cacodylate buffer for 1 h. Subsequently,
the eyes were cut in half and the anterior segment was re-
moved. Fixed eyes were washed three times for 10 min at
room temperature with PBS. Specimen were embedded in
paraffin, sectioned to 3–5 µm thickness and stained with
hematoxylin and eosin according to standard procedures.
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